Literature DB >> 18419381

Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006.

Amy A Parker1, Meredith A Reynolds, Jessica Leung, Meredith Anderson, Araceli Rey, Ismael R Ortega-Sanchez, D Scott Schmid, Dalya Guris, Kathleen F Gensheimer.   

Abstract

In June 2005, the Advisory Committee on Immunization Practices (ACIP) recommended administering a second dose of varicella vaccine during outbreaks, supplementing the routine 1-dose requirement. From October 2005 to January 2006, a varicella outbreak occurred in Maine in a highly vaccinated elementary school population. We investigated the outbreak, held a school-based vaccination clinic, and assessed costs in implementing ACIP's outbreak-response recommendation. Parents completed questionnaires and case investigation interviews. Personnel at the Maine Center for Disease Control and Prevention, the school in which the outbreak occurred ("school A"), and physician offices completed economic surveys. Forty-eight cases occurred, with no hospitalizations or deaths. Vaccine effectiveness was 86.6% (95% confidence interval, 82.0%-90.1%). Of 240 eligible students, 132 (55.0%) received second-dose vaccination. Implementing ACIP's outbreak-response recommendation was challenging and cost approximately $26,875. Additionally, the routine 1-dose varicella vaccination policy did not confer adequate population immunity to prevent this outbreak. These findings support ACIP's June 2007 recommendation for a routine 2-dose varicella vaccination program.

Mesh:

Substances:

Year:  2008        PMID: 18419381     DOI: 10.1086/522134

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Lijun Zhai; Qingxiu Zheng; Xinghuo Pang; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

2.  Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV.

Authors:  Silvio Tafuri; Domenico Martinelli; Rosa Prato; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

3.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

Review 4.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

5.  Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Authors:  Dana Perella; Chengbin Wang; Rachel Civen; Kendra Viner; Karen Kuguru; Irini Daskalaki; D Scott Schmid; Adriana S Lopez; Hung Fu Tseng; E Claire Newbern; Laurene Mascola; Stephanie R Bialek
Journal:  Pediatrics       Date:  2016-03-14       Impact factor: 7.124

Review 6.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Seroepidemiology of varicella in Hangzhou, China in the vaccine era.

Authors:  Yuyang Xu; Shijun Liu; Xinren Che; Yan Liu; Xuechao Zhang; Jian Du; Xiaoping Zhang; Jun Wang; Erping Xu
Journal:  Hum Vaccin Immunother       Date:  2018-07-30       Impact factor: 3.452

8.  Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Authors:  Johannes Horn; André Karch; Oliver Damm; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; Hartmut Hengel; Wolfgang Greiner; Rafael T Mikolajczyk
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

9.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 10.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.